Natco Pharma received Emergency Use approval By Mr. Yash Gupta, Angel Broking Ltd
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
Below are Quote on Natco Pharma received Emergency Use approval by Mr. Yash Gupta Equity Research Associate, Angel Broking Ltd
Natco Pharma Limited has received Emergency Use approval for Baricitinib tablets, 1mg, 2mg and 4mg strengths from Central Drugs Standard Control Organization (CDSCO) in India. Baricitinib in combination with Remdesivir, is used for treatment of COVID-19 positive patients. Natco will be requesting a Compulsory License based on emergency use and in light of the grave and serious public health emergency across India due to the Pandemic. The company is ready to launch the product this week, so as to make the product available to suffering patients across India. This can be a very good launch for natco pharma, we expect this will be a limited period opportunity for the company.
Above views are of the author and not of the website kindly read disclaimer
Tag News
On the higher side, immediate resistance is seen around 36000 - 36200 levels - Angel One
